Vaccines help to provide increased immunity to a disease. To immunise against both COVID-19 and influenza, a combination vaccine is being developed that will contain vaccines against both COVID-19 and influenza in one injection.

We are looking for males and females who:

• are between 50 and 70 years old;
• are in good general health;
• have received both COVID-19 vaccinations or have had COVID-19 at least 8 weeks prior to the first vaccination visit;
• can attend all scheduled visits to the clinic (8 times over 6 months).

There will be additional screening criteria discussed over the phone with research coordinators.

The study will involve up to 3 vaccinations using an intramuscular injection (similar to receiving a flu vaccine) spaced between 2 to 3 months apart.

Eligible participants will be reimbursed for their time and expenses related to the study.

For further information or to register your interest, please click the link below.

Full title: A Phase 1/2, Randomized, Observer-Blinded Study to Evaluate the Safety and Immunogenicity of a Quadrivalent Hemagglutinin Nanoparticle Influenza and SARS-CoV-2 rS Nanoparticle Combination Vaccine with Matrix-M™ Adjuvant in Healthy Participants ≥ 50 to ≤ 70 Years of Age

HREC approval: Alfred Hospital Ethics Committee